Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • COVID-19 and cancer
    • Culturally and Linguistically Diverse (CALD)
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Oesophageal cancer

oesophageal-mm affected-cancer/cancer-types/oesophageal-cancer
    • Home
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Follow-up
    • Finding support
    • Home
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Follow-up
    • Finding support
  1. Home
  2. Statistics

Oesophageal cancer statistics in Australia

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Oesophageal cancer incorporates ICD-10 cancer codes C15 (Malignant neoplasm of oesophagus). 


Estimated number of new cases of oesophageal cancer diagnosed in 2020

1,587 = male icon 1,153 males + female icon 434 females


Estimated % of all new cancer cases diagnosed in 2020

1.1%


Estimated number of deaths from oesophageal cancer in 2020

1,351 = male icon 1,003 males + female icon 348 females


Estimated % of all deaths from cancer in 2020

2.8%


Chance of surviving at least 5 years (2012–2016)

22%


People living with oesophageal cancer at the end of 2014 (diagnosed in the 5 year period 2010 to 2014)

2,544


New cases

In 2016, there were 1,489 new cases of oesophageal cancer diagnosed in Australia (1,089 males and 400 females). In 2020, it is estimated that 1,587 new cases of oesophageal cancer will be diagnosed in Australia (1,153 males and 434 females).

Figure 1. Estimated most common cancers diagnosed, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

In 2016, the age-standardised incidence rate was 5.3 cases per 100,000 persons (8.2 for males and 2.6 for females). In 2020, it is estimated that the age-standardised incidence rate will be 5.0 cases per 100,000 persons (7.7 for males and 2.5 for females). The incidence rate for oesophageal cancer is expected to increase with age, peaking at age group 85-89.

Figure 2. Age-standardised incidence rates for oesophageal cancer, 1982 to 2016, by sex

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for oesophageal cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

The number of new cases of oesophageal cancer diagnosed increased from 537 (317 males and 220 females) in 1982 to 1,489 in 2016. Over the same period, the age-standardised incidence rate increased slightly from 4.4 cases per 100,000 persons (5.7 for males and 3.2 for females) in 1982 to 5.3 cases per 100,000 in 2016.

Deaths 

In 2018, there were 1,329 deaths from oesophageal cancer in Australia (987 males and 342 females). In 2020, it is estimated that there will be 1,351 deaths (1,003 males and 348 females).

Figure 3. Estimated most common causes of cancer death, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

In 2018, the age-standardised mortality rate was 4.4 deaths per 100,000 persons (7.0 for males and 2.0 for females). In 2020, it is estimated that the age-standardised mortality rate will be 4.2 deaths per 100,000 persons (6.8 for males and 2.0 for females). The mortality rate for oesophageal cancer is expected to increase with age.

Figure 4. Age-standardised mortality rates for oesophageal cancer, 1982 to 2018, by sex

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for oesophageal cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

The number of deaths from oesophageal cancer increased from 527 (338 males and 189 females) in 1982 to 1,329 in 2018. Over the same period, the age-standardised mortality rate remained at 4.4 deaths per 100,000 persons (6.4 for males and 2.9 for females) in 1982, and 2018. 

Survival 

In 2012–2016, individuals diagnosed with oesophageal cancer had a 22 % chance (22% for males and 23% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2012–2016, five-year relative survival for oesophageal cancer improved from 11% to 22%.

Figure 5. 5-year relative survival for oesophageal cancer, 1987–1991 to 2012–2016, by sex

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about 5-year relative survival rates for oesophageal cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival) 

Prevalence 

At the end of 2015, there were 976 people living who had been diagnosed with oesophageal cancer that year, 2,544 people living who had been diagnosed with oesophageal cancer in the previous 5 years (from 2011 to 2015) and 4,437 people living who had been diagnosed with oesophageal cancer in the previous 34 years (from 1982 to 2015).

For more information, see Oesophageal cancer on the NCCI website 

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 22 October 2020 - 4:25pm

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia